The new pill, called AD109, is a combination of atomoxetine and aroxybutynin, two drugs that tell your brain to keep the ...

Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea reduced the ...

This can lead to delays in diagnosis as sleep apnea in women can be mistaken for anxiety, depression and menopause. As the signs are more subtle, research suggests as many as 90% of women who have ...

Obstructive sleep apnea is still largely undiagnosed and untreated. In a growing marketplace of solutions, can negative ...

Apnimed, Inc., a pharmaceutical company advancing an industry-leading pipeline of first-in-class oral therapies that address the root causes of obstructive sleep apnea (OSA) and other sleep-related ...

The possibility of a dementia diagnosis may have a new origin, according to a recent study from UC Irvine. Medical research ...

A retrospective study shows sleep apnea can increase the risk for retinal vein occlusion in both men and women and is ...

A new study found active-duty service members with sleep apnea face a greater risk of PTSD or a traumatic brain injury, ...

If left untreated, obstructive sleep apnea raises the risk of hypertension, heart disease, type 2 diabetes, depression and even an early death, according to the American Academy of Sleep Medicine.

Most associate sleep apnea with snoring, but it’s the sound of silence doctors say patients should be concerned with.

Data suggest that OSA diagnoses were associated with an increased risk for physical and psychological problems in active-duty ...